Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8180
|
pubmed:dateCreated |
1980-8-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1245-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6155578-Aprotinin,
pubmed-meshheading:6155578-Diabetes Mellitus,
pubmed-meshheading:6155578-Female,
pubmed-meshheading:6155578-Humans,
pubmed-meshheading:6155578-Injections, Subcutaneous,
pubmed-meshheading:6155578-Insulin,
pubmed-meshheading:6155578-Insulin Resistance,
pubmed-meshheading:6155578-Middle Aged
|
pubmed:year |
1980
|
pubmed:articleTitle |
Resistance against subcutaneous insulin successfully managed with aprotinin.
|
pubmed:publicationType |
Letter,
Case Reports
|